by | Dec 13, 2024 | Silva-Fisher, Jessica
— Value Proposition: Long non-coding RNA as biomarker and therapeutic target for treating diagnosed multiple myeloma patients.
Technology Description
Researchers at Washington University in St. Louis have developed a long non-coding RNA as a diagnostic marker and clinical target for multiple my…
by | Oct 28, 2024 | Dolle, Roland "Ron", Zhou, Mingzhou
— Value Proposition: Small molecule Gastrin-releasing peptide receptor (GRPR) antagonists used to treat chronic itch.
Technology Description
Researchers at Washington University in St. Louis have discovered a group of small molecule Gastrin-releasing peptide receptor (GRPR) antagonists to treat c…
by | Oct 24, 2024 | Breshears, Jonathan, Leuthardt, Eric
— Value Proposition: New technique for examining active brain areas in unconscious neurosurgical patients.
Technology Description
Researchers at Washington University in St. Louis have developed a new process that includes a new use for existing electrocorticographic (ECoG) grids, an amplifier, an…
by | Oct 22, 2024 | Brunner, Peter, Leuthardt, Eric
— Value Proposition: New process used to detect/measure the intrinsic neuronal brain activity to diagnose neurological and psychiatric diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a method called Tau-Modulation to assess intrinsic neuronal activi…
by | Oct 22, 2024 | Brunner, Peter, Leuthardt, Eric, Willie, Jon, Xie, Tao
— Value proposition: Method and system for removing multiple types of brain stimulation artifacts in neural signals to improve neurological diagnoses and therapies.
Technology Description
Researchers at Washington University in St. Louis have developed a method to remove brain stimulation artifact…